V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260017687 | 260008292 | 1.76 | null | Disease modification (D) | 2017-10-30 | 2018-06-29 | Rituximab | Y | N | 260025700 | RITUXIMAB |
| 260017688 | 260016663 | null | 72 | Adjuvant (A) | 2016-07-23 | 2016-07-23 | Rituximab | 99 | null | 260025713 | RITUXIMAB |
| 260017689 | 260008298 | 1.53 | 108.3 | Curative (C) | 2018-01-24 | 2018-02-05 | Rituximab | 02 | N | 260025714 | RITUXIMAB |
| 260017690 | 260008302 | 1.61 | 0 | Curative (C) | 2016-06-19 | 2016-06-21 | Rituximab | 2 | N | 260025719 | RITUXIMAB |
| 260017691 | 260008304 | 1.8 | null | Palliative (P) | 2019-05-13 | 2019-05-18 | Rituximab | 2 | N | 260025721 | RITUXIMAB |
| 260017692 | 260008309 | null | 59.6 | Neo-adjuvant (N) | 2014-05-13 | 2014-05-23 | Rituximab | 02 | N | 260025723 | RITUXIMAB |
| 260017693 | 260008311 | 1.67 | null | Disease modification (D) | 2015-10-03 | 2015-10-12 | Rituximab (Maintenance) | N | N | 260025727 | RITUXIMAB |
| 260017694 | 260008313 | 1.71 | 77 | Palliative (P) | 2015-10-07 | 2015-10-15 | Rituximab | 02 | N | 260025728 | RITUXIMAB |
| 260017695 | 260008317 | 1.61 | null | Disease modification (D) | 2018-04-17 | 2018-04-29 | Rituximab (Maintenance) | 2 | N | 260025735 | RITUXIMAB |
| 260017696 | 260008323 | 1.63 | 71.7 | Palliative (P) | 2017-07-14 | 2017-07-22 | Rituximab | 02 | N | 260025741 | RITUXIMAB |
| 260017697 | 260008328 | null | null | Disease modification (D) | 2014-05-08 | 2014-07-02 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 260025745 | RITUXIMAB |
| 260017698 | 260008331 | null | 98.1 | Disease modification (D) | 2016-12-25 | 2018-04-08 | Rituximab | N | N | 260025754 | RITUXIMAB |
| 260017699 | 260008333 | null | null | Curative (C) | 2017-09-13 | 2017-10-04 | Rituximab | N | N | 260025757 | RITUXIMAB |
| 260017700 | 260008335 | 1.67 | null | null | null | 2016-08-26 | Rituximab (Maintenance) | N | N | 260025762 | RITUXIMAB |
| 260017701 | 260008341 | 1.8 | 101.2 | Disease modification (D) | 2015-10-28 | 2015-11-23 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 260025768 | BENDAMUSTINE + RITUXIMAB |
| 260017702 | 260008348 | 1.79 | null | Curative (C) | 2017-06-17 | 2017-07-07 | BEP 3 day | 02 | N | 260025775 | BEP |
| 260017703 | 260016671 | 1.68 | 97 | Palliative (P) | 2014-11-29 | 2014-12-03 | BEP 5 Day | N | N | 260025777 | BEP |
| 260017704 | 260008354 | 1.67 | 110 | Palliative (P) | 2014-05-31 | 2016-05-06 | BEP 3 day | 02 | N | 260025782 | BEP |
| 260017705 | 260008355 | 1.72 | null | null | 2016-08-13 | 2016-08-19 | BEP 5 Day | N | N | 260025788 | BEP |
| 260017706 | 260008361 | 0 | 62 | Adjuvant (A) | 2017-05-12 | 2017-06-25 | BEP 3 day | 2 | N | 260025805 | BEP |
| 260017707 | 260008363 | 1.8 | 90.3 | Curative (C) | 2017-04-16 | 2017-04-16 | BEP 3 day | N | N | 260025814 | BEP |
| 260017708 | 260016675 | 1.58 | 72 | Not known (9) | 2016-10-18 | 2016-10-25 | BEP 5 Day | 02 | N | 260025815 | BEP |
| 260017709 | 260008367 | 1.57 | 118.4 | Curative (C) | 2014-09-04 | 2014-09-05 | BEP 3 day | 2 | N | 260025831 | BEP |
| 260017710 | 260013959 | 1.57 | 56 | Curative (C) | 2014-03-03 | 2014-03-10 | BENDAMUSTINE + RITUXIMAB | N | N | 260025832 | BENDAMUSTINE + RITUXIMAB |
| 260017711 | 260008370 | 1.69 | 69 | Curative (C) | 2016-12-01 | 2016-12-29 | BEP 3 day | N | N | 260025834 | BEP |
| 260017712 | 260008376 | 1.82 | 90.3 | Curative (C) | null | 2017-11-15 | BEP 3 day | 2 | N | 260025868 | BEP |
| 260017713 | 260008377 | null | 124.6 | Curative (C) | 2015-03-28 | 2015-04-26 | BENDAMUSTINE + RITUXIMAB | N | N | 260025872 | BENDAMUSTINE + RITUXIMAB |
| 260017714 | 260008381 | 1.88 | 101.3 | Disease modification (D) | 2015-12-14 | 2016-02-28 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025875 | BENDAMUSTINE + RITUXIMAB |
| 260017715 | 260008386 | 1.86 | 92.5 | Curative (C) | 2017-04-27 | 2017-09-20 | BEP 3 day | N | N | 260025887 | BEP |
| 260017716 | 260008388 | null | 89.1 | Curative (C) | null | 2018-04-01 | BEP 3 day | N | null | 260025888 | BEP |
| 260017717 | 260008390 | 1.93 | 76.4 | Curative (C) | 2016-03-30 | 2016-03-31 | BEP 3 day | N | N | 260025889 | BEP |
| 260017718 | 260016684 | 1.73 | 98 | Curative (C) | 2015-01-14 | 2015-02-05 | BEP 3 day | 02 | N | 260025893 | BEP |
| 260017719 | 260008394 | 1.77 | 80 | Curative (C) | 2017-02-06 | 2017-02-11 | BEP 5 Day | 2 | N | 260025901 | BEP |
| 260017720 | 260008395 | 1.7 | 62 | Adjuvant (A) | 2015-04-17 | 2015-05-07 | BEP 3 day | N | null | 260025904 | BEP |
| 260017721 | 260016687 | 1.74 | 63 | Disease modification (D) | 2018-11-02 | 2018-11-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260025905 | BENDAMUSTINE + RITUXIMAB |
| 260017722 | 260008400 | 2 | 60 | Curative (C) | 2015-10-28 | 2015-10-28 | BEP 3 day | N | N | 260025908 | BEP |
| 260017723 | 260013980 | 1.6 | 86 | Palliative (P) | 2016-12-13 | 2016-12-26 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025921 | BENDAMUSTINE + RITUXIMAB |
| 260017724 | 260008410 | 1.87 | 106.8 | Curative (C) | 2017-04-15 | 2017-06-03 | BEP 3 day | N | N | 260025930 | BEP |
| 260017725 | 260008413 | 1.57 | 98 | Palliative (P) | null | 2016-12-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025936 | BENDAMUSTINE + RITUXIMAB |
| 260017726 | 260008418 | 1.7 | 118 | Adjuvant (A) | 2017-07-14 | 2017-08-15 | BENDAMUSTINE + RITUXIMAB | null | N | 260025937 | BENDAMUSTINE + RITUXIMAB |
| 260017727 | 260008420 | null | null | Curative (C) | 2013-11-09 | 2013-12-06 | BEP 5 Day | null | N | 260025947 | BEP |
| 260017728 | 260008422 | 1.79 | null | Curative (C) | 2017-06-08 | 2017-08-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260025956 | BENDAMUSTINE + RITUXIMAB |
| 260017729 | 260008430 | 1.59 | 57.7 | Curative (C) | 2017-08-03 | 2017-08-29 | BEP 5 Day | 2 | N | 260025968 | BEP |
| 260017730 | 260008435 | 0 | 90 | Curative (C) | 2016-10-27 | 2016-11-30 | BEP 3 day | 02 | N | 260025977 | BEP |
| 260017731 | 260016692 | 1.64 | null | Palliative (P) | 2016-08-12 | 2017-02-03 | Bendamustine+Rituximab(Sub Courses) | null | null | 260025978 | BENDAMUSTINE + RITUXIMAB |
| 260017733 | 260008454 | 1.83 | 68 | Curative (C) | 2017-07-16 | 2017-09-12 | BEP 5 Day | N | N | 260026007 | BEP |
| 260017734 | 260014002 | 1.74 | 81 | Curative (C) | 2017-10-04 | 2017-10-31 | BEP 3 day | N | N | 260026008 | BEP |
| 260017735 | 260016696 | 1.62 | 74 | Curative (C) | 2018-04-27 | 2018-05-04 | BENDAMUSTINE + RITUXIMAB | N | N | 260026023 | BENDAMUSTINE + RITUXIMAB |
| 260017736 | 260018026 | 1.67 | 74.3 | Palliative (P) | 2016-06-12 | 2016-07-23 | BEP 5 Day | N | N | 260026025 | BEP |
| 260017737 | 260008461 | 1.7 | 71 | Curative (C) | 2014-12-18 | 2014-12-25 | BEP 3 day | 02 | N | 260026026 | BEP |